Methotrexate inhibition of CCRF-CEM cultures of human lymphoblasts
- 30 November 1975
- journal article
- Published by Elsevier BV in European Journal of Cancer (1965)
- Vol. 11 (11), 771-782
- https://doi.org/10.1016/0014-2964(75)90170-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A method for assessing dihydrofolate reductase inhibition in vivoAnalytical Biochemistry, 1972
- Thymidylate synthetase from amethopterin- resistant Lactobacillus caseiBiochemistry, 1971
- Tetrahydrofolate-dependent enzymes in Sarcoma 180 cells sensitive and resistant to amethopterinBiochemical Pharmacology, 1968
- Sensitivity of cultured human lymphoblasts (CCRF-CEM cells) to inhibition by thymidineExperimental Cell Research, 1966
- Uptake as a Determinant of Methotrexate Response in Mouse LeukemiasScience, 1965
- The “induction” of leukocyte and erythrocyte dihydrofolate reductase by methotrexateCancer Cell, 1965
- The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in miceBiochemical Pharmacology, 1963
- Further observations on the site of action of amethopterinBiochemical Pharmacology, 1963
- Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cellsBiochemical Pharmacology, 1961
- Specific Binding of 4-Amino Folic Acid Analogues by Folic Acid ReductasePublished by Elsevier BV ,1961